Title : Once-weekly trelagliptin versus daily alogliptin in Japanese patients with type 2 diabetes: a randomised, double-blind, phase 3, non-inferiority study.

Pub. Date : 2015 Mar

PMID : 25609193






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND: Trelagliptin is a novel once-weekly oral DPP-4 inhibitor. trelagliptin dipeptidyl peptidase 4 Homo sapiens
2 INTERPRETATION: The once-weekly DPP-4 inhibitor trelagliptin showed similar efficacy and safety to alogliptin once daily in Japanese patients with type 2 diabetes. trelagliptin dipeptidyl peptidase 4 Homo sapiens